ANTIBODIES

Contributor Information
- Name Ayham Alnabulsi
- Institute Vertebrate Antibodies Limited
Tool Details
- Tool name: Anti-Cytochrome P450 1B1 [5E2]
- Clone: 500
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human ; Mouse ; Rat
- Host: Mouse
- Molecular weight of the target: 52 kDa
- Application: ELISA ; IHC ; WB
- Strain: Balb/c
- Description: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.Participates in the metabolism of an as-yet-unknown biologically active molecule that is a participant in eye development. CYP1B1 is upregulated in tumour cells and is a therapeutic target
- Immunogen: Ovalbumin-conjugated synthetic peptide - PENFDPARFLDKDGL
- Isotype: IgG1 kappa
- Research area: Cancer; Cell Signaling & Signal Transduction; Metabolism
- For Research Use Only
Target Details
- Target: Cytochrome P450, Family 1, Subfamily B, Polypeptide 1, CYP1B1
- Target molecular weight: 52 kDa
- Target background: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.Participates in the metabolism of an as-yet-unknown biologically active molecule that is a participant in eye development. CYP1B1 is upregulated in tumour cells and is a therapeutic target
Application Details
- Application: ELISA ; IHC ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15°C to -25°C
- Shipping conditions: Shipping at 4°C
Related Tools
References
- • McFadyen et al. 1999. J Histochem Cytochem. 47(11):1457-64. PMID: 10544218.
- • Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1.